Kimberley S. Mak

2.2k total citations
50 papers, 948 citations indexed

About

Kimberley S. Mak is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kimberley S. Mak has authored 50 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 14 papers in Oncology. Recurrent topics in Kimberley S. Mak's work include Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Head and Neck Cancer Studies (8 papers). Kimberley S. Mak is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Head and Neck Cancer Studies (8 papers). Kimberley S. Mak collaborates with scholars based in United States, United Kingdom and Australia. Kimberley S. Mak's co-authors include Haesun A. Kim, Amy D. Guertin, John A. Alberta, Muhammad M. Qureshi, Andrzej Niemierko, Minh Tam Truong, Scott L. Pomeroy, Kei Suzuki, Tracy A. Balboni and Ümit Tapan and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Kimberley S. Mak

48 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberley S. Mak United States	16	315	271	252	182	119	50	948
Roberto Orozco United States	16	281 0.9×	690 2.5×	137 0.5×	94 0.5×	133 1.1×	40	1.1k
S. Glüer Germany	21	645 2.0×	367 1.4×	139 0.6×	57 0.3×	381 3.2×	68	1.3k
Daniel R. Simpson United States	21	283 0.9×	730 2.7×	354 1.4×	67 0.4×	145 1.2×	60	1.5k
Manuel S. Eisenberg United States	17	575 1.8×	667 2.5×	121 0.5×	68 0.4×	415 3.5×	29	1.3k
Catherine Liebig United States	5	521 1.7×	305 1.1×	674 2.7×	142 0.8×	124 1.0×	8	1.3k
Douglas C. Miller United States	20	510 1.6×	352 1.3×	122 0.5×	76 0.4×	378 3.2×	37	1.7k
Rinat Yacobi Israel	9	81 0.3×	195 0.7×	270 1.1×	21 0.1×	360 3.0×	13	1.2k
G Fine United States	20	362 1.1×	381 1.4×	261 1.0×	140 0.8×	395 3.3×	62	1.4k
Dae Hee Han South Korea	25	173 0.5×	750 2.8×	66 0.3×	133 0.7×	117 1.0×	85	2.1k
Jung‐Hyun Yang South Korea	26	483 1.5×	330 1.2×	711 2.8×	27 0.1×	183 1.5×	82	2.0k

Countries citing papers authored by Kimberley S. Mak

Since Specialization

Citations

This map shows the geographic impact of Kimberley S. Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberley S. Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberley S. Mak more than expected).

Fields of papers citing papers by Kimberley S. Mak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberley S. Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberley S. Mak. The network helps show where Kimberley S. Mak may publish in the future.

Co-authorship network of co-authors of Kimberley S. Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberley S. Mak. A scholar is included among the top collaborators of Kimberley S. Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberley S. Mak. Kimberley S. Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Yue, Muhammad M. Qureshi, Sonny Batra, M.T. Truong, & Kimberley S. Mak. (2024). Consecutive Daily Versus Every Other Day Stereotactic Body Radiation Therapy Scheduling for Stage I Non-small Cell Lung Cancer. Advances in Radiation Oncology. 9(12). 101625–101625.

Omari, Omar Al, Mohini Patel, Kiana Mahdaviani, et al.. (2024). The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patients. The Oncologist. 30(3). 1 indexed citations

Ciechanowicz, Sarah, Jae Ho Kim, Kimberley S. Mak, et al.. (2023). Outcomes and outcome measures utilised in randomised controlled trials of postoperative caesarean delivery pain: a scoping review. International Journal of Obstetric Anesthesia. 57. 103927–103927. 2 indexed citations

Qureshi, Muhammad M., Yue Lin, S.X. Yan, et al.. (2023). Change in stage after neoadjuvant chemoradiation is associated with survival in patients with esophageal cancer. Journal of Surgical Oncology. 128(5). 781–789. 1 indexed citations

Oladeru, Oluwadamilola T., Muhammad M. Qureshi, Ariel E. Hirsch, et al.. (2023). Inequalities in Cancer Stage at Diagnosis Among Incarcerated Individuals Undergoing Radiation Therapy at a Large Safety-Net Hospital. International Journal of Radiation Oncology*Biology*Physics. 116(1). 194–198. 2 indexed citations

Qureshi, Muhammad M., Kei Suzuki, Virginia R. Litle, et al.. (2023). Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer. Surgery. 173(5). 1153–1161. 2 indexed citations

Qureshi, Muhammad M., et al.. (2022). Frailty Index is Associated with Treatment Decisions for Stage I Non-Small Cell Lung Cancer at a High-Burden Safety-Net Hospital. Clinical Lung Cancer. 24(2). 153–164. 1 indexed citations

Liu, Anqi, et al.. (2022). Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net Hospital. Journal of Racial and Ethnic Health Disparities. 10(6). 2836–2843. 8 indexed citations

Matthews, Benjamin, Muhammad M. Qureshi, Stephen Fiascone, et al.. (2021). Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Gynecologic Oncology. 164(1). 27–33. 5 indexed citations

10.

Qureshi, Muhammad M., et al.. (2021). Longitudinal Outcomes of Medical Student Research Mentorship: a 15-Year Analysis of the Radiation Oncology Mentorship Initiative. Journal of Cancer Education. 38(1). 153–160. 6 indexed citations

11.

Qureshi, Muhammad M., et al.. (2021). Consecutive Daily vs. Every Other Day SBRT Scheduling for Stage I NSCLC. International Journal of Radiation Oncology*Biology*Physics. 111(3). e444–e444. 1 indexed citations

12.

Lin, Yue, Muhammad M. Qureshi, Ümit Tapan, et al.. (2021). Reducing delays to lung cancer treatment through systematic consult scheduling: A multidisciplinary quality improvement initiative at a safety-net hospital.. Journal of Clinical Oncology. 39(15_suppl). e18640–e18640. 1 indexed citations

13.

Poulson, Michael, Kimberley S. Mak, Ümit Tapan, et al.. (2021). The Impact of Residential Racial Segregation on Non-Small Cell Lung Cancer Treatment and Outcomes. The Annals of Thoracic Surgery. 113(4). 1291–1298. 32 indexed citations

14.

Shah, Nishant K., Muhammad M. Qureshi, Michael A. Dyer, Minh Tam Truong, & Kimberley S. Mak. (2020). Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival. Journal of Gastrointestinal Cancer. 52(1). 229–236. 6 indexed citations

15.

Yan, S.X., Muhammad M. Qureshi, Michael A. Dyer, Minh Tam Truong, & Kimberley S. Mak. (2019). Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer. Lung Cancer. 131. 147–153. 7 indexed citations

16.

Mak, Kimberley S., Stephanie W. Lee, Tracy A. Balboni, & Karen J. Marcus. (2017). Clinical outcomes and toxicity following palliative radiotherapy for childhood cancers. Pediatric Blood & Cancer. 65(1). 8 indexed citations

17.

Mak, Kimberley S., A.C.M. van Bommel, Caleb Stowell, et al.. (2015). Defining a Standard Set of Patient Centered Outcomes for Patients With Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). E403–E403. 1 indexed citations

18.

Mak, Kimberley S., Justin F. Gainor, Andrzej Niemierko, et al.. (2014). Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. Neuro-Oncology. 17(2). 296–302. 69 indexed citations

19.

Burdach, Jon, Alister P. W. Funnell, Kimberley S. Mak, et al.. (2013). Regions outside the DNA-binding domain are critical for proper in vivo specificity of an archetypal zinc finger transcription factor. Nucleic Acids Research. 42(1). 276–289. 33 indexed citations

20.

Guertin, Amy D., et al.. (2005). Microanatomy of Axon/Glial Signaling during Wallerian Degeneration. Journal of Neuroscience. 25(13). 3478–3487. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact